A Mars Sample Return Strategic Review team NASA formed in October 2024 assessed the studies and recommended the sampling program’s main architecture, including schedule and cost estimates.
Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty ...